Mx GTPases: Dynamin-like antiviral machines of innate immunity

Trends in Microbiology

Volumn 23, Issue 3, 2015, Pages 154-163

  Haller, Otto ^a   Staeheli, Peter ^a   Schwemmle, Martin ^a   Kochs, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Dynamin like GTPase; HIV 1; Influenza; Innate immunity; Interferon; Primate evolution

Indexed keywords

DYNAMIN; GUANOSINE TRIPHOSPHATASE; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN; MYXOVIRUS RESISTANCE PROTEIN A; MYXOVIRUS RESISTANCE PROTEIN B; UNCLASSIFIED DRUG;

AVIAN INFLUENZA VIRUS; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; LENTIVIRINAE; LIFE CYCLE; MX GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; VERTEBRATE; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; PHYLOGENY; PHYSIOLOGY; VIRAL PHENOMENA AND FUNCTIONS; VIRUS;

AVES; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA A VIRUS; PRIMATES;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; IMMUNITY, INNATE; INFLUENZA A VIRUS; MODELS, MOLECULAR; MYXOVIRUS RESISTANCE PROTEINS; ORTHOMYXOVIRIDAE; PHYLOGENY; VIRUS PHYSIOLOGICAL PHENOMENA; VIRUS REPLICATION; VIRUSES;

EID: 84925410974     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2014.12.003     Document Type: Review

References (107)

1. Horisberger M.A., et al. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc. Natl. Acad. Sci. U.S.A. 1983, 80:1910-1914.
2. Staeheli P., et al. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 1986, 44:147-158.
3. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B: Biol. Sci. 1957, 147:258-267.
4. Lindenmann J. Resistance of mice to mouse-adapted influenza A virus. Virology 1962, 16:203-204.
5. Lindenmann J. Of mice and man - The Mx connection. Comprehensive Biochemistry 2005, 44:267-295. Elsevier B.V.
6. Haller O., et al. Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. J. Interferon Res. 1987, 7:647-656.
7. Staeheli P., et al. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol. 1988, 8:4518-4523.
8. Haller O., et al. Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J. Biol. Chem. 2010, 285:28419-28424.
9. Haller O., Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 2011, 31:79-87.
10. Verhelst J., et al. Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol. Mol. Biol. Rev. 2013, 77:551-566.
11. Schoggins J.W., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472:481-485.
12. Everitt A.R., et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012, 484:519-523.
13. Arnheiter H., et al. Transgenic mice with intracellular immunity to influenza virus. Cell 1990, 62:51-61.
14. Kolb E., et al. Resistance to influenza virus infection of Mx transgenic mice expressing Mx protein under the control of two constitutive promoters. J. Virol. 1992, 66:1709-1716.
15. Haller O., et al. Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J. Exp. Med. 1981, 154:199-203.
16. Tumpey T.M., et al. The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses. J. Virol. 2007, 81:10818-10821.
17. Deeg C., et al. Transgenic mice carrying interferon-regulated MxA locus are highly resistant to avian but not human influenza A viruses. Cytokine 2013, 63:258.
18. Ferris M.T., et al. Modeling host genetic regulation of influenza pathogenesis in the collaborative cross. PLoS Pathog. 2013, 9:e1003196.
19. Horisberger M.A., et al. cDNA cloning and assignment to chromosome 21 of IFI-78K gene, the human equivalent of murine Mx gene. Somat. Cell Mol. Genet. 1988, 14:123-131.
20. Staeheli P., Sutcliffe J.G. Identification of a second interferon-regulated murine Mx gene. Mol. Cell. Biol. 1988, 8:4524-4528.
21. Jin H.K., et al. Identification of the murine Mx2 gene: interferon-induced expression of the Mx2 protein from the feral mouse gene confers resistance to vesicular stomatitis virus. J. Virol. 1999, 73:4925-4930.
22. Jin H.K., et al. Mouse Mx2 protein inhibits hantavirus but not influenza virus replication. Arch. Virol. 2001, 146:41-49.
23. Jin H.K., et al. Characterization and expression of the Mx1 gene in wild mouse species. Biochem. Genet. 1998, 36:311-322.
24. Guenet J.L., Bonhomme F. Wild mice: an ever-increasing contribution to a popular mammalian model. Trends Genet. 2003, 19:24-31.
25. Asano A., et al. Mouse Mx2 gene: organization, mRNA expression and the role of the interferon-response promoter in its regulation. Gene 2003, 306:105-113.
26. Gerardin J.A., et al. Genomic structure, organisation, and promoter analysis of the bovine (Bos taurus) Mx1 gene. Gene 2004, 326:67-75.
27. Hug H., et al. Organization of the murine Mx gene and characterization of its interferon- and virus-inducible promoter. Mol. Cell. Biol. 1988, 8:3065-3079.
28. Holzinger D., et al. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J. Virol. 2007, 81:7776-7785.
29. Mordstein M., et al. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses. PLoS Pathog. 2008, 4:e1000151.
30. Jorns C., et al. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha. J. Med. Virol. 2006, 78:74-82.
31. Roers A., et al. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J. Infect. Dis. 1994, 169:807-813.
32. Mibayashi M., et al. Promoted cell death of cells expressing human MxA by influenza virus infection. Microbiol. Immunol. 2002, 46:29-36.
33. Li Y., Youssoufian H. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups. J. Clin. Invest. 1997, 100:2873-2880.
34. van der Bliek A.M., Payne G.S. Dynamin subunit interactions revealed. Dev. Cell 2010, 18:687-688.
35. Gao S., et al. Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity 2011, 35:514-525.
36. Fribourgh J.L., et al. Structural Insight into HIV-1 Restriction by MxB. Cell Host Microbe 2014, 16:627-638.
37. Chappie J.S., et al. An intramolecular signaling element that modulates dynamin function in vitro and in vivo. Mol. Biol. Cell 2009, 20:3561-3571.
38. Rennie M.L., et al. Transient dimerization of human MxA promotes GTP hydrolysis, resulting in a mechanical power stroke. Structure 2014, 22:1433-1445.
39. Di Paolo C., et al. Intramolecular backfolding of the carboxyl-terminal end of MxA protein is a prerequisite for its oligomerization. J. Biol. Chem. 1999, 274:32071-32078.
40. Gao S., et al. Structural basis of oligomerization in the stalk region of dynamin-like MxA. Nature 2010, 465:502-506.
41. Accola M.A., et al. The antiviral dynamin family member, MxA, tubulates lipids and localizes to the smooth endoplasmic reticulum. J. Biol. Chem. 2002, 277:21829-21835.
42. Kochs G., et al. Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers. J. Biol. Chem. 2002, 277:14172-14176.
43. von der Malsburg A., et al. Stalk domain of the dynamin-like MxA GTPase protein mediates membrane binding and liposome tubulation via the unstructured L4 loop. J. Biol. Chem. 2011, 286:37858-37865.
44. Mitchell P.S., et al. Evolution-guided identification of antiviral specificity determinants in the broadly acting interferon-induced innate immunity factor MxA. Cell Host Microbe 2012, 12:598-604.
45. Patzina C., et al. Structural requirements for the antiviral activity of the human MxA protein against Thogoto and influenza A virus. J. Biol. Chem. 2014, 289:6020-6027.
46. Melen K., et al. Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope. J. Biol. Chem. 1996, 271:23478-23486.
47. King M.C., et al. Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8957-8962.
48. Pavlovic J., et al. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 1992, 66:2564-2569.
49. Haller O., et al. Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1. J. Virol. 1995, 69:2596-2601.
50. Zurcher T., et al. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 1992, 187:796-800.
51. Zurcher T., et al. Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J. Virol. 1992, 66:5059-5066.
52. Engelhardt O.G., et al. Mx1 GTPase accumulates in distinct nuclear domains and inhibits influenza A virus in cells that lack promyelocytic leukaemia protein nuclear bodies. J. Gen. Virol. 2004, 85:2315-2326.
53. Chelbi-Alix M.K., et al. Induction of the PML protein by interferons in normal and APL cells. Leukemia 1995, 9:2027-2033.
54. Engelhardt O.G., et al. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies. Exp. Cell Res. 2001, 271:286-295.
55. Stertz S., et al. Interferon-induced, antiviral human MxA protein localizes to a distinct subcompartment of the smooth endoplasmic reticulum. J. Interferon Cytokine Res. 2006, 26:650-660.
56. Johnston S.C., et al. In vitro inhibition of monkeypox virus production and spread by Interferon-beta. Virol. J. 2012, 9:5.
57. Netherton C.L., et al. Inhibition of a large double-stranded DNA virus by MxA protein. J. Virol. 2009, 83:2310-2320.
58. Reichelt M., et al. Missorting of LaCrosse virus nucleocapsid protein by the interferon-induced MxA GTPase involves smooth ER membranes. Traffic 2004, 5:772-784.
59. Haller O., Kochs G. Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002, 3:710-717.
60. Hoff F., et al. The large GTPase Mx1 Is involved in apical transport in MDCK cells. Traffic 2014, 15:983-996.
61. Goujon C., et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 2013, 502:559-562.
62. Kibenge M.J., et al. Constitutive expression of Atlantic salmon Mx1 protein in CHSE-214 cells confers resistance to infectious salmon anaemia virus. Virol. J. 2005, 2:75.
63. Larsen R., et al. Inhibition of infectious pancreatic necrosis virus replication by atlantic salmon Mx1 protein. J. Virol. 2004, 78:7938-7944.
64. Pitossi F., et al. A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J. Virol. 1993, 67:6726-6732.
65. Ponten A., et al. Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J. Virol. 1997, 71:2591-2599.
66. Yu Z., et al. GTPase activity is not essential for the interferon-inducible MxA protein to inhibit the replication of hepatitis B virus. Arch. Virol. 2008, 153:1677-1684.
67. Mitchell P.S., et al. An evolutionary perspective on the broad antiviral specificity of MxA. Curr. Opin. Microbiol. 2013, 16:493-499.
68. Fricke T., et al. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 2014, 11:68.
69. Goujon C., et al. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance fFactor. J. Virol. 2014, 88:9017-9026.
70. Kane M., et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013, 502:563-566.
71. Liu Z., et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 2013, 14:398-410.
72. Busnadiego I., et al. Host and viral determinants of Mx2 antiretroviral activity. J. Virol. 2014, 88:7738-7752.
73. Melen K., Julkunen I. Nuclear cotransport mechanism of cytoplasmic human MxB protein. J. Biol. Chem. 1997, 272:32353-32359.
74. Broni B., et al. Parental influenza virion nucleocapsids are efficiently transported into the nuclei of murine cells expressing the nuclear interferon-induced Mx protein. J. Virol. 1990, 64:6335-6340.
75. Krug R.M., et al. Inhibition of influenza viral mRNA synthesis in cells expressing the interferon-induced Mx gene product. J. Virol. 1985, 56:201-206.
76. Kochs G., Haller O. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2082-2086.
77. Xiao H., et al. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J. Virol. 2013, 87:13053-13058.
78. Pavlovic J., et al. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 1990, 64:3370-3375.
79. Zurcher T., et al. Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J. 1992, 11:1657-1661.
80. Schwemmle M., et al. Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology 1995, 206:545-554.
81. Staeheli P., Pavlovic J. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J. Virol. 1991, 65:4498-4501.
82. Zhao H., et al. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA. Virology 1996, 220:330-338.
83. Kochs G., et al. Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3153-3158.
84. Li N., et al. MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen. Hepatology 2012, 56:803-811.
85. Fackler O.T., Keppler O.T. MxB/Mx2: the latest piece in HIV's interferon puzzle. EMBO Rep. 2013, 14:1028-1029.
86. Haller O. Dynamins are forever: MxB inhibits HIV-1. Cell Host Microbe 2013, 14:371-373.
87. Arnheiter H., Haller O. Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins. EMBO J. 1988, 7:1315-1320.
88. Miura T.A., et al. Expression of human MxA protein in mosquito cells interferes with LaCrosse virus replication. J. Virol. 2001, 75:3001-3003.
89. Landis H., et al. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 1998, 72:1516-1522.
90. Schneider-Schaulies S., et al. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 1994, 68:6910-6917.
91. Wisskirchen C., et al. Interferon-induced antiviral protein MxA interacts with the cellular RNA helicases UAP56 and URH49. J. Biol. Chem. 2011, 286:34743-34751.
92. Dittmann J., et al. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J. Virol. 2008, 82:3624-3631.
93. Zimmermann P., et al. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J. Virol. 2011, 85:8133-8140.
94. Manz B., et al. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog. 2013, 9:e1003279.
95. Kochs G., Haller O. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae). J. Biol. Chem. 1999, 274:4370-4376.
96. Turan K., et al. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res. 2004, 32:643-652.
97. Verhelst J., et al. Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. J. Virol. 2012, 86:13445-13455.
98. Huang T., et al. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J. Virol. 1992, 66:4154-4160.
99. Stranden A.M., et al. Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology 1993, 197:642-651.
100. Frese M., et al. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 1996, 70:915-923.
101. Kanerva M., et al. Inhibition of Puumala and Tula hantaviruses in Vero cells by MxA protein. Virology 1996, 224:55-62.
102. Bridgen A., et al. Inhibition of Dugbe nairovirus replication by human MxA protein. Virus Res. 2004, 99:47-50.
103. Andersson I., et al. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J. Virol. 2004, 78:4323-4329.
104. Chieux V., et al. Inhibition of coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology 2001, 283:84-92.
105. Mundt E. Human MxA protein confers resistance to double-stranded RNA viruses of two virus families. J. Gen. Virol. 2007, 88:1319-1323.
106. Thimme R., et al. Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. Virology 1995, 211:296-301.
107. Frese M., et al. Mx1 sensitivity: Batken virus is an orthomyxovirus closely related to Dhori virus. J. Gen. Virol. 1997, 78:2453-2458.